文献速递糖尿病

遗传风险评分提升1型糖尿病个体冠状动脉疾病风险预测

Genetic Risk Score Enhances Coronary Artery Disease Risk Prediction in Individuals With Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2022-01-01

研究纳入芬兰糖尿病肾病研究中3295例1型糖尿病个体(467例新发冠状动脉疾病,随访14.8年),比较遗传风险评分、经验证临床评分及联合评分的预测效能。遗传风险评分最高与最低第5百分位间冠状动脉疾病HR为6.7,其预测效能与HbA1c、HDL及总胆固醇相似,联合评分预测效能优于临床评分,遗传风险评分在低于中位年龄38.6岁的个体中表现更好。

要点

  • 遗传风险评分最高与最低第5百分位间冠状动脉疾病HR为6.7(P=1.8×10^-6)。
  • 遗传风险评分C-index=0.562,与HbA1c、HDL及总胆固醇预测效能相似。
  • 联合评分C-index=0.813 vs 临床评分C-index=0.820(P=0.003),联合评分优于临床评分。

核心结论

  • 遗传风险评分可识别冠状动脉疾病高风险个体,在较年轻个体中表现更好。
  • 遗传风险评分是冠状动脉疾病的独立危险因素,预测效能与HbA1c、HDL及总胆固醇相当,纳入临床模型后适度改善预测。
  • 遗传风险评分有望通过增强冠状动脉疾病预测,在临床实践中实现早期风险分层。

研究设计与样本

  • 研究纳入芬兰糖尿病肾病研究中3295例1型糖尿病个体,随访14.8年,新发冠状动脉疾病467例。
  • 使用三种风险评分:遗传风险评分、经验证临床评分及两者联合评分。
  • 采用Cox回归计算风险比(HR),以Harrell C-index比较模型效能。

主要发现

  • 遗传风险评分最高与最低第5百分位间冠状动脉疾病HR为6.7(P=1.8×10^-6)。
  • 遗传风险评分C-index=0.562,与HbA1c C-index=0.563(差异P=0.96)、HDL C-index=0.571(P=0.6)、总胆固醇C-index=0.594(P=0.1)相似。
  • 遗传风险评分与临床评分不相关(r=-0.013,P=0.5)。
  • 联合评分C-index=0.813 vs 临床评分C-index=0.820(P=0.003),联合评分优于临床评分。
  • 遗传风险评分在低于中位年龄38.6岁个体中C-index=0.637 vs 高于者C-index=0.546。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Individuals with type 1 diabetes are at a high lifetime risk of coronary artery disease (CAD), calling for early interventions. This study explores the use of a genetic risk score (GRS) for CAD risk prediction, compares it to established clinical markers, and investigates its performance according to the age and pharmacological treatment. RESEARCH DESIGN AND METHODS: This study in 3,295 individuals with type 1 diabetes from the Finnish Diabetic Nephropathy Study (467 incident CAD, 14.8 years follow-up) used three risk scores: a GRS, a validated clinical score, and their combined score. Hazard ratios (HR) were calculated with Cox regression, and model performances were compared with the Harrell C-index (C-index). RESULTS: A HR of 6.7 for CAD was observed between the highest and the lowest 5th percentile of the GRS (P = 1.8 × 10-6). The performance of GRS (C-index = 0.562) was similar to HbA1c (C-index = 0.563, P = 0.96 for difference), HDL (C-index = 0.571, P = 0.6), and total cholesterol (C-index = 0.594, P = 0.1). The GRS was not correlated with the clinical score (r = -0.013, P = 0.5). The combined score outperformed the clinical score (C-index = 0.813 vs. C-index = 0.820, P = 0.003). The GRS performed better in individuals below the median age (38.6 years) compared with those above (C-index = 0.637 vs. C-index = 0.546). CONCLUSIONS: A GRS identified individuals at high risk of CAD and worked better in younger individuals. GRS was also an independent risk factor for CAD, with a predictive power comparable to that of HbA1c and HDL and total cholesterol, and when incorporated into a clinical model, modestly improved the predictions. The GRS promises early risk stratification in clinical practice by enhancing the prediction of CAD.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Lithovius R, Antikainen AA, Mutter S, et al. Genetic Risk Score Enhances Coronary Artery Disease Risk Prediction in Individuals With Type 1 Diabetes. Diabetes Care. 2022. PMID: 35019974. doi:10.2337/dc21-0974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。